Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy of Topical Bupivacaine and Triamcinolone Acetonide Injection in the Relief of Pain After Endoscopic Submucosal Dissection for Gastric Neoplasia: A Randomized Double-blind, Placebo-controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age, between 20 and 80~* Patients who were scheduled to undergo ESD for gastric epithelial neoplasm at Severance Hospital between July 2012 and April 2013~Exclusion Criteria:~* Not providing written informed consent~* A history of any cardiac arrhythmias~* Current or regular use of analgesic medication for other indications~* Known other disease such as peptic ulcer disease or reflux esophagitis which could induce upper gastrointestinal pain~* Multiple lesions requiring ESD in a single patient~* Evidence of infectious disease or antibiotics therapy within 7 days prior to enrollment~* Participation in another clinical trial within 30 days prior enrollment~* Current pregnancy or breast feeding.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Control group (Type: PLACEBO_COMPARATOR): None
- Bupivacaine only group (Type: EXPERIMENTAL): None
- Bupivacaine with triamcinolone group (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).